Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 218329Generated: October 29, 2026

Triethylamine → 1-methyl-2-[2-(5-phenyl-[1,2,4]oxadiazol-3-yl)-morpholin-4-yl]-1H-[4,4']bipyrimidinyl-6-one

https://huagongshe.com/reaction/218329

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTriethylamineHCID 8471—
Reactant(2S)-2-(4-bromophenyl)oxiraneHCID 12163514—
Reactant1-methyl-2-(2-(3-phenyl-[1,2,4]oxadiazol-5-yl)-morpholin-4-yl)-1H-[4,4']bipyrimidinyl-6-oneHCID 57798788—
Reactant2-(5-Phenyl-1,2,4-oxadiazol-3-yl)morpholine hydrochlorideHCID 66842498—
SolventTetrahydrofuranHCID 8028—
Product1-methyl-2-[2-(5-phenyl-[1,2,4]oxadiazol-3-yl)-morpholin-4-yl]-1H-[4,4']bipyrimidinyl-6-oneHCID 5779878764%

Reaction Steps

A solution of the resulting 2-(5-phenyl-[1,2,4]oxadiazol-3-yl)-morpholine hydrochloride (intermediate 10 in tetrahydrofuran (6.0 ml) was added with 2-chloro-3-methyl-6-(pyrimidine-4-yl)pyrimidin-4-one (intermediate 1, 260 mg, 2.34 mmol) and triethylamine (1.81 ml, 13.0 mmol), and the reaction mixture was stirred at room temperature for 2 hours. The solution was partitioned between water and chloroform, and the organic layer was washed with water and brine, dried over magnesium sulfate, and concentrated in vacuo. The resulting residue was purified by column chromatography on silica gel (eluent; 5% methanol in chloroform) to afford 1-methyl-2-[2-(5-phenyl-[1,2,4]oxadiazol-3-yl)-morpholin-4-yl]-1H-[4,4′]bipyrimidinyl-6-one (compound 2 in Table 1, 749 mg, 64%, 2 steps) as solid

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08198437B2
Source datasetuspto-grants-2012_06
ORD IDord-835d49e4d97345a8911b542bdbe2ca09
Source noteuspto-grants-2012_06